Clinical trial
The Safety and Effectiveness of Megace in HIV-Infected Women
NCT00002345 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00002345 |
|---|---|
| Title | The Safety and Effectiveness of Megace in HIV-Infected Women |
| Official title | Phase IV Study on the Safety and Efficacy of Megace Oral Suspension in HIV-Positive Females |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anorexia, Cachexia, HIV Infections |
| Intervention type | Drug |
| Interventions | Megestrol acetate |
| Enrollment | 40 |
| First posted | Aug 31, 2001 |
| Last update posted | Oct 2, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: